Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RCD regimen
Introduction
Overview
Overview
RCD regimen refers to a regimen consisting of rituximab, cyclophosphamide, and dexamethasone used to treat monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas.[1] and autoimmune cytopenias associated with chronic lymphocytic leukemia.[2]
Regimen
Regimen
RRituximab
CCyclophosphamide
DDexamethasone
References
References
- ↑ 1.0 1.1 Perry M, Delarche A, Ribes D, Vergez F, Guilbeau-Frugier C, Laurent C; et al. (2014). “Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas”. Am J Hematol. 89 (10): 969–73. doi:10.1002/ajh.23798. PMID 25043930.
- ↑ 2.0 2.1 Michallet AS, Rossignol J, Cazin B, Ysebaert L (2011). “Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia”. Leuk Lymphoma. 52 (7): 1401–3. doi:10.3109/10428194.2011.591005. PMID 21699387.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]